798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update

• Aaron Scott,
• Manish Patel,
• Julie Bauman,
• Jeffrey Clarke,
• Howard Burris,
• Justin Gainor,
• Martin Gutierrez,
• Daniel Cho,
• Ricklie Julian,
• Pamela Cohen,
• Joshua Frederick,
• Celine Robert-Tissot,
• Honghong Zhou,
• Kinjal Mody,
• Karen Keating,
• Robert Meehan

Affiliations

Aaron Scott

1University of Arizona, Tuscon, AZ, USA

Manish Patel

6Florida Cancer Specialists, Sarasota, FL, USA

Julie Bauman

1University of Arizona, Tuscon, AZ, USA

Jeffrey Clarke

3Duke, Durham, NC, USA

Howard Burris

2SCRI, Nashville, TN, USA

Justin Gainor

8Mass General Hospital, Boston, MA, USA

Martin Gutierrez

3Hackensack University Medical Center, Hackensack, NJ, USA

Daniel Cho

11NYU Medical Oncology Associates, New York, NY, USA

Ricklie Julian

1University of Arizona, Tuscon, AZ, USA

Pamela Cohen

7Moderna, Tenafly, NJ, USA

Joshua Frederick

7Moderna, Tenafly, NJ, USA

Celine Robert-Tissot

7Moderna, Tenafly, NJ, USA

Honghong Zhou

7Moderna, Tenafly, NJ, USA

Kinjal Mody

7Moderna, Tenafly, NJ, USA

Karen Keating

7Moderna, Tenafly, NJ, USA

Robert Meehan

7Moderna, Tenafly, NJ, USA